Thermo Fisher's stock slips after deal to buy Sweden's Olink for a 74% premium
Thermo Fisher Scientific Inc. TMO, +1.18% announced Tuesday an agreement to buy Sweden-based proteomics company Olink Holding AB OLK, +0.47% in a deal that values Olink at about $3.1 billion, inclu...
Thermo Fisher's (TMO) Strong End Markets and New Buyouts Aid
Thermo Fisher (TMO) is registering strong growth in the electron microscopy and chromatography and mass spectrometry businesses in the academic and government end market.
Thermo Fisher Scientific (TMO) Increases Yet Falls Behind Market: What Investors Need to Know
The latest trading day saw Thermo Fisher Scientific (TMO) settling at $498.55, representing a +0.11% change from its previous close.
Thermo Fisher (TMO) Expands Capabilities in St. Louis Facility
Thermo Fisher (TMO) expands manufacturing capacity at the St. Louis site for Biologics treatment.
Thermo Fisher Scientific: Transforming Healthcare Leadership Post-COVID-19 Pandemic
Thermo Fisher Scientific is a leading research and development company and provider of laboratory products and services headquartered in Waltham. On August 23, Reuters announced that Novo Nordisk h...
Thermo Fisher: I'm Waiting For A Better Valuation In This High-Quality Business
Thermo Fisher Scientific provides laboratory instruments, reagents, and consumables for scientific research and healthcare applications. These are the 'picks and shovels' for healthcare and life sc...
Will Thermo Fisher Scientific Stock Recover To Its Pre-Inflation Shock Highs?
This underperformance of TMO stock can partly be attributed to declining sales of its Life Sciences segment due to lower COVID-19-related demand.
Thermo Fisher (TMO) to Advance Clinical Research With New Pact
Thermo Fisher's clinical research division will aid in increasing community health clinics' capacity to participate in clinical studies.
Thermo Fisher (TMO) Adds New Platform to CTS Product Portfolio
Thermo Fisher (TMO) launches the next-generation Gibco CTS Detachable Dynabeads platform.
Why Is Thermo Fisher (TMO) Down 3.9% Since Last Earnings Report?
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch
Thermo Fisher (TMO) announces the commercial launch of the EXTENT Solution with IVDR certification.
Thermo Fisher (TMO) Launches New Chromosomal Microarray
Thermo Fisher's (TMO) CytoScan HD Accel array can save labs weeks or even months by accelerating the time it takes to get findings from cytogenetic research.
Novo hires Thermo Fisher as 2nd manufacturer for Wegovy weight-loss drug - source
Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy, a source familiar with the matter told Reuters.
Thermo Fisher (TMO) Business Hurt by Low COVID Sales, FX Woe
Thermo Fisher (TMO) is witnessing headwinds in the government and academic end markets.
Thermo Fisher (TMO) Completes the CorEvitas Acquisition
Thermo Fisher's (TMO) latest buyout is likely to deliver $0.03 in adjusted earnings per share in 2024 and be marginally accretive in 2023.
Related Companies